Goldman Sachs
FEED

Goldman Sachs’s ENvue Medical Inc FEED Stock Holding History

Goldman Sachs’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28
Closed -$64K – 6793
2021
Q4 		$64K Buy
+28
New +$83.2K ﹤0.01% 6221
2018
Q1 		– Sell
-7
Closed -$69K – 6222
2017
Q4 		$69K Buy
+7
New +$70.1K ﹤0.01% 5855

Other funds holding FEED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFS
Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Goldman Sachs's FEED Position: Q1 2022 in Review

Goldman Sachs sold out of ENvue Medical Inc (FEED) in Q1 2022, closing a stake of 28 shares — an estimated $64K sold.

Goldman Sachs first reported a position in FEED in Q4 2017 and held it in 2 quarters. The position peaked at $69K in Q4 2017. 18 funds tracked by Wall St. Rank hold FEED as of Q1 2022.

  • Goldman Sachs reported no remaining ENvue Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 28 ENvue Medical Inc shares in Q1 2022, an estimated $64K.
  • Goldman Sachs first reported a position in ENvue Medical Inc in Q4 2017 and held it in 2 quarters.
  • Goldman Sachs's ENvue Medical Inc position peaked at $69K in Q4 2017.
  • 18 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.